LT - Medžiagų derinys, skirtas naudoti 1 tipo cukriniu diabetu sergančių pacientų regeneracinei terapijai
EN - A COMBINATION OF SUBSTANCES FOR USE IN REGENERATIVE THERAPY IN PATIENTS WITH TYPE 1 DIABETES MELLITUS
Legal status
Patent in force
Bibliographic data
Indications of the International Patent Classification (IPC)
(51) |
INT.CL. |
A61K 31/19 |
(2006.01) |
|
|
A61K 31/197 |
(2006.01) |
|
|
A61K 31/403 |
(2006.01) |
|
|
A61K 31/4439 |
(2006.01) |
|
|
A61K 31/4985 |
(2006.01) |
|
|
A61K 31/513 |
(2006.01) |
|
|
A61K 31/5513 |
(2006.01) |
|
|
A61P 3/10 |
(2006.01) |
European patent
(11) |
Number of the document |
3520786 |
(13) |
Kind of document |
T |
(96) |
European patent application number |
18182706.4 |
|
Date of filing the European patent application |
2018-07-10 |
(97) |
Date of publication of the European application |
2019-08-07 |
(45) |
Date of publication and mention of the grant of the patent |
2023-08-09
|
(46) |
Date of publication of the claims translation |
2023-10-10
|
Priority applications
(30) |
Number |
Date |
Country code |
|
2018104548 |
2018-02-06
|
RU |
Inventors
(72) |
LEVIT, Shmuel Boris , IL
|
Grantee
(73) |
LEVICURE Ltd. ,
Mania 10/7 b,, Rishon LeZiyon 7524166,
IL
|
Attorney or representative
(74) |
Gediminas PRANEVIČIUS,
Advokatų profesinė bendrija IP FORMA, Užupio g. 30, LT-01203 Vilnius,
LT
|
Title
(54) |
Medžiagų derinys, skirtas naudoti 1 tipo cukriniu diabetu sergančių pacientų regeneracinei terapijai |
|
A COMBINATION OF SUBSTANCES FOR USE IN REGENERATIVE THERAPY IN PATIENTS WITH TYPE 1 DIABETES MELLITUS |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2024-06-14 |
7 |
162.00
EUR
|
Next renewal fee
|
2025-07-10 |